Drug-related infectious diseases (DRID) expert meeting

Drug-related infectious diseases (DRID) expert meeting

Date and place: 
EMCDDA, Lisbon, 15-16 June 2017


The EMCDDA DRID expert meeting brings together specialists from across Europe to discuss the latest developments in drug-related infectious diseases in Europe, covering the main topic areas of epidemiology, responses and monitoring.

The meeting provides a space for sharing and discussing new studies, new findings and experiences at regional, national and European level. It also aims to facilitate technical work around the collection and analysis of the different components of this key epidemiological indicator: prevalence of infections among drug users, surveillance data and behavioural data. The overall purpose of this event is to reinforce and improve the completeness, robustness and utility of the information collected and analysed in order to inform policy decisions and developments in the field. The DRID expert meeting focuses on the following topics: outbreaks, incidents and emerging risks, regional assessment of HIV risk and responses; and follow-up of the assessment of the implementation of the DRID Key indicator.

EMCDDA/ECDC Hepatitis week

This year, back to back with the DRID meeting, EMCDDA will also host the 4th meeting of the ECDC hepatitis B and C network, on 12-14 June 2017. A joint day on 14 June will give the networks an opportunity to share expertise and experience, and in particular to discuss how Europe can improve its surveillance of and response to hepatitis among people who inject drugs, and how the networks can contribute to achieving the targets for elimination set out by WHO. In addition, experts will discuss practical evidence-based strategies, share examples of good practices and identify solutions to common challenges.

While attendance at the expert meeting is restricted to nominated experts from the 30 EMCDDA member countries (28 EU Member States, Norway and Turkey), national experts from candidate and potential candidate countries, representatives from partner agencies (ECDC, WHO Europe) as well as invited speakers, the main findings and highlights of the discussions, as well as experts’ presentations are available on the EMCDDA website. A ‘Rapid communication’ will also be available to bring the results of the meeting to a wider audience.

Expert Presentations

Session 6. Monitoring PWIDs access to hepatitis care - the role of national policies

Outputs of the meeting